Guggenheim Capital LLC Sol Gel Technologies Ltd. Call Options Transaction History
Guggenheim Capital LLC
- $13.9 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SLGL
# of Institutions
22Shares Held
7.33MCall Options Held
5.4KPut Options Held
0-
Phoenix Holdings Ltd. Givatayim, L32.47MShares$1.48 Million0.03% of portfolio
-
Armistice Capital, LLC New York, NY2.03MShares$1.22 Million0.02% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.1.23MShares$736,5280.01% of portfolio
-
Harel Insurance Investments & Financial Services Ltd.920KShares$552,1990.01% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3229KShares$137,5060.03% of portfolio
About Sol-Gel Technologies Ltd.
- Ticker SLGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,129,500
- Market Cap $13.9M
- Description
- Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company's lead product candidates include Twyneo, a novel, once-daily, non-antibiotic topical cream which has compl...